To examine associations between sleep disturbance and changes in weight and body composition and the mediating role of changes of appetite and food cravings in the Preventing Overweight Using Novel Dietary Strategies (POUNDS Lost) 2-year weight-loss diet intervention trial, this study included 810 overweight or obese individuals with baseline sleep disturbance assessment who were randomly assigned one of four diets varying in macronutrient composition. Changes in body weight and fat distribution were assessed by DEXA and computed tomography during the 2-year intervention. Participants were asked to provide sleep disturbance levels (no, slight, moderate, or great) at baseline and to recall their sleep disturbances since last visit at 6, 12, 18, and 24 months. Weight loss during the first 6 months was followed by 1.5 years of steady weight regain. Participants with greater sleep disturbance from baseline to 6 months showed significant losses of body weight (Ptrend <0.001) and waist circumference (Ptrend = 0.002) at 6 months, after multivariate adjustment. Compared with individuals without sleep disturbance at all from baseline to 6 months, those with slight, moderate, or great sleep disturbance showed an elevated risk of failure to lose weight (−5% or more loss) at 6 months, when the maximum weight loss was achieved, with an odds ratio of 1.24 (95% CI 0.87, 1.78), 1.27 (95% CI 0.75, 2.13), or 3.12 (95% CI 1.61, 6.03), respectively. In addition, we observed that the repeatedly measured levels of sleep disturbance over 2 years were inversely associated with the overall weight loss rate (weight changes per 6 months) (Ptrend <0.001). Further, sleep disturbances during weight loss from baseline to 6 months and weight regain from 6 months to 24 months were significantly predictive of total fat, total fat mass percent, and trunk fat percent changes during the 2 years. Our results also indicated that food cravings for carbohydrates/starches, fast food fats, and sweets; cravings, prospective consumption, hunger of appetite measurements; and dietary restraint, disinhibition, and hunger subscales measured at 6 months significantly mediated the effects of sleep disturbance on weight loss. In conclusion, our results suggested that more severe sleep disturbance during weight loss was associated with an elevated risk of failure to lose weight during the dietary intervention. Food cravings and eating behaviors may partly mediate these associations.

The rapidly developing obesity epidemic, which has been implicated in the development of cardiovascular diseases and type 2 diabetes (1), has posed a great challenge to public health. Diet and lifestyle modifications are among the major interventional approaches in obesity management. Even though various dietary interventions successfully induce weight loss among participants who are overweight or obese, a proportion of the participants failed to lose body weight or to maintain initial weight loss (2), indicating considerable interindividual variability. Several potential mechanisms, such as differences in compliance to the interventions, markers of dietary protein intake, and genetic heterogeneity, have been proposed to explain such variability (36), but there is still a gap in understanding other behavioral factors that may also account for these observations.

Compelling evidence has shown that sleep duration and sleep quality play a pivotal role in regulating body weight and fat distribution (711). However, whether sleep behaviors affect weight loss and maintenance in response to various calorie-restricted diets remains unclear. Several previous interventions tested the impact of curtailing sleep on body weight and body composition during diet-induced weight loss, but mixed results hindered the interpretations of these associations (1219). Interpretation of many of these studies is limited by their short duration of intervention, lack of generalizability, lack of repeated measurements, missing information on important covariates, and small sample size. Thus, an investigation on the relation between sleep behavior and long-term weight loss and fat distribution is needed. Notably, a number of causal pathways linking short sleep duration with obesity have been discussed in a systematic review, such as appetite and food cravings (11,20,21). However, no study has comprehensively assessed whether these changes mediate the effects of sleep behavior and weight loss in the context of long-term dietary weight-loss interventions.

In the current study, we investigated whether sleep disturbance, defined as disorders of initiation, maintenance of sleep, disruptions of circadian rhythms, excessive somnolence, and dysfunctions associated with sleep, sleep stages, or partial arousals (22) were associated with weight loss, weight regain, and changes in body fat weight and body fat distribution in a 2-year randomized dietary intervention study called Preventing Overweight Using Novel Dietary Strategies (POUNDS Lost).

Study Participants

The POUNDS Lost study was a 2-year randomized study of diet intervention, in which 811 participants who were overweight or obese were randomly assigned to one of four energy-reduced diets consisting of different composition of macronutrients (fat, protein, and carbohydrate) to compare their effects on body weight (23). Two diets were low in fat (20%), and the other two were high in fat (40%). There were also two diets that differed in protein, one with average protein (15%) and the other high protein (25%), constituting a 2-by-2 factorial design. The two high-fat diets were also low-carbohydrate diets, in which the energy derived from carbohydrate was 35% and 45%, respectively. Each participant’s caloric prescription represented a deficit of 750 kcal/day from measured resting energy expenditure (REE) at baseline. Participants with diabetes, unstable cardiovascular disease, use of medications that affected body weight, and insufficient motivations were ineligible for the POUNDS Lost trial. Fifty percent of the total individuals were randomly selected to undergo DEXA scans at baseline, after 6 months, and 2 years (24). Of those with DEXA scans, 50% had abdominal fat measured by computed tomography (CT). We used a cutoff of 5% of initial body weight to define successful weight losers (25,26). According to the U.S. Food and Drug Administration, the lower bound of weight loss to reach clinically meaningful health benefits is 5% of body weight (27). In brief, most weight loss was observed after 6 months of diet intervention, with 421 individuals losing >5%. Gradual weight regain occurred from 6 to 24 months. No difference of weight loss was detected comparing four diet groups.

In POUNDS Lost, there were 810 participants with baseline assessment of sleep disturbance. Of those, 511 had complete assessments of sleep disturbance every 6 months over 2 years (see missing patterns of sleep disturbances in Supplementary Table 1). The protocol was approved by the Institutional Review Board at Harvard T.H. Chan School of Public Health, Brigham and Women’s Hospital, and the Pennington Biomedical Research Center of the Louisiana State University System, as well as by a data and safety monitoring board appointed by the National Heart, Lung, and Blood Institute. All participants provided written informed consent.

Measurements of Sleep Disturbances

The information on sleep disturbances were self-reported. The standardized questionnaires about symptoms and medical reporting, including sleep disturbances, were administered by interviewers at baseline and every 6 months in the 2-year study period. Participants were asked to provide their baseline sleep disturbance information and to recall their levels of sleep disturbance since last visit at 6 months, 12 months, 18 months, and 24 months. Disturbance in sleep was rated in four categories from “not at all,” “slight amount,” “moderate amount,” to “great amount.” All interviewers received standardized training, and possible responses were read to the participants verbatim. The questionnaires about symptoms and medical reporting are included in the Supplementary Material.

Measurements of Body Composition and Adiposity

Height was measured at the baseline examination. Body weight and waist circumference were assessed in the morning before breakfast at baseline and every 6 months during the intervention. Participants’ body weights were collected by calibrated hospital scales and waist circumferences using a nonstretchable tape measure, 4 cm above the iliac crest. BMI was calculated as weight in kilograms divided by the square of height in meters. The DEXA scan was conducted using a Hologic QDR 4500A (Hologic) after an overnight fast; total fat mass, total lean mass, whole body total fat mass percentage, and trunk fat percentage were measured at baseline, 6 months, and 24 months during the intervention. CT scans were performed, and total adipose tissue mass, visceral adipose tissue mass, deep subcutaneous adipose tissue mass, and superficial adipose tissue mass within the abdomen were assessed by standard methods at baseline, 6 months, and 24 months. Measurements of REE were performed for all trial participants at baseline, 6, and 24 months. Details of the assessment of REE have been reported previously (28).

Measurements of Appetite, Food Cravings, and Other Eating Behaviors

The Food Craving Inventory (FCI) is a 33-item, self-administrated tool to obtain how often the individual experiences craving. A Likert scale between 1 and 5 was used to describe levels of craving for particular foods, where 1 = never, 2 = rarely, 3 = sometimes, 4 = often, and 5 = always (29). There are also five subscales in the FCI, including high-fat foods (i.e., steak, fried fish, and fried chicken), sweets (e.g., cake, cookies, chocolate, and candy), carbohydrates/starches (i.e., rolls, baked potato, pasta, and cereal), fast-food fats (i.e., pizza, hamburgers, French fries, and chips), and fruits/vegetables.

Appetites of participants were acquired by using a motivation-to-eat visual analog scale (VAS) at baseline, 6 months, and 24 months (30,31), which has four questions: 1) how strong is your desire to eat? (“very weak” to “very strong” to assess craving); 2) how hungry do you feel? (“not hungry at all” to “as hungry as I’ve ever felt” to assess hunger); 3) how full do you feel? (“very full” to “not full at all” to assess fullness); and 4) how much food do you think you could eat? (“nothing at all” to “a large amount” to assess prospective consumption).

While fasting, participants completed the questionnaires before breakfast, between 0700 and 0900 h on a weekly basis, by placing a cursor on the 100-mm VASs to assess craving, hunger, fullness, and prospective consumption. Higher scores indicate greater levels. A total appetite score was calculated as appetite score = (craving + hunger + [100 − fullness] + prospective consumption)/4 at each visit time (30,32). The reliability and validity of the VASs have been reported previously (33).

The Three-Factor Eating Questionnaire (TFEQ) is a self-report measure consisting of 51 yes/no questions to evaluate cognitive restraint, disinhibition (susceptibility to overeating), and perceived hunger (34).

Dietary restraint refers to the intent to diet, intent to monitor, and regulate food intake (21 items). The disinhibition scale assesses uncontrolled eating in response to different stimuli, such as in the presence of palatable foods or emotional clues (16 items). The perceived hunger scale measures the tendency to eat in response to the subjective sense of hunger (14 items). Higher scores reflect higher levels of cognitive restraint, disinhibition, and perceived hunger.

Other Covariates

The Baecke questionnaire was used to assess physical activity (35). Levels of physical activity were indicated by physical activity score, calculated based on physical activity at work, sport during leisure time, and other physical activity during leisure time.

Statistical Analysis

The primary outcomes of interest in this study were: 1) weight loss at 6 months and overall weight loss rate (weight change per 6 months) over 2 years; 2) weight regain rate (weight change per 6 months) from 6 months to 2 years; and 3) changes of body composition and fat distribution from baseline to 6 months and 6 months to 2 years.

Participants in the intervention achieved a maximum weight loss of 6.2% (−5.75 kg) at 6 months. After 6 months, most of them tended to regain weight and end up with an overall weight loss of 3.5% (−3.31 kg) at 2 years. Therefore, we categorized the study period from months 0 to 6 as weight loss period and months 6 to 24 as weight regain period. All statistical analysis are performed as post hoc analysis of the data collected from POUNDS Lost trial.

Multivariate-adjusted models controlling age, sex, ethnicity, diet intervention, BMI, and physical activity were used to assess the relationship between sleep disturbance from baseline to 6 months and weight loss at 6 months. Respective outcome traits at previous visits were further adjusted to test the association between sleep disturbance and changes in body composition and adiposity. In addition, we conducted analyses to examine the effect of sleep disturbances on weight changes (0–24 months and 6–24 months) using the generalized estimating equation (GEE), with a first-order autoregressive matrix. Sleep disturbance assessed at 6, 12, 18, and 24 months as well as weight changes at 6, 12, 18, and 24 months were included in the GEE models. The least squares (LS) means of weight loss rate according to levels of sleep disturbance were calculated. Tests for linear trend were conducted by including an ordinal variable of sleep disturbance in the model. To investigate the impact of sleep disturbance from baseline to 6 months on successful weight loss at 6 months, we further performed a logistic regression to calculate odds ratios (ORs) and 95% CIs for a failure of achieving successful weight loss.

The magnitude of mediation by psychologic and behavioral factors was assessed by calculating change of β coefficient for sleep disturbance comparing two generalized linear models predicting weight loss: 1) adjusting for age, sex, ethnicity, diet, BMI, and physical activity; and 2) further adjusting for each of the potential mediating factors individually. Due to power consideration and significant linear trend, sleep disturbance was coded as an ordinal variable in the generalized linear model. Also, we combined “slight” and “moderate” sleep disturbance levels, as their effects on weight change at 6 months are not significantly distinct in a sensitivity analysis (Table 2). The 95% CIs for the change of β coefficient between the two models were calculated using bootstrap methods with 1,000 replications.

A two-sided P < 0.05 was considered statistically significant. All statistical analyses were performed with SAS software, version 9.4 (SAS Institute Inc., Cary, NC).

Data and Resource Availability

The data sets generated during and/or analyzed during the current study are available from the corresponding author upon reasonable request. No applicable resources were generated or analyzed during the current study.

Table 1 presents the baseline characteristics of study participants. Mean (SD) value for age was 50.9 (9.2) and 32.7 (3.9) kg/cm2 for BMI. Of the 810 participants, 79% were White, and 68% possessed a college degree or higher. The prevalence of no, slight, moderate, and great sleep disturbance were 57%, 29%, 12%, and 2%, respectively. Compared with females, male participants were less likely to have sleep disturbance (P = 0.02). No significant differences were observed for age, sex, race, BMI, weight, physical activity, REE, and diet intervention allocation across different levels of sleep disturbance. A total of 511 (63%) participants completed all the five assessments (baseline, 6 months, 12 months, 18 months, and 24 months) of sleep disturbance and weight changes during the 2-year intervention (Supplementary Table 1). Among them, 221 (43%), 206 (40%), 228 (45%), and 212 (41%) participants’ levels of sleep disturbance at 6, 12, 18, and 24 months, respectively, were different from previous measurements.

Table 1

Characteristics of study participants according to sleep disturbance at the baseline examination

OutcomesNot at all (n = 462)Slight (n = 236)Moderate (n = 95)Great (n = 17)P*
Age (years) 50.56 (9.03) 51.24 (9.34) 51.45 (9.80) 50.13 (8.83) 0.70 
Male 187 (40.48) 71 (30.08) 35 (36.84) 3 (17.65) 0.02 
High-fat diet 230 (49.78) 118 (50.00) 49 (51.58) 8 (47.06) 0.98 
BMI (kg/m232.74 (3.79) 32.57 (4.07) 32.97 (3.45) 31.94 (5.00) 0.82 
Body weight (kg) 93.43 (15.66) 91.67 (15.74) 93.91 (13.54) 89.98 (19.82) 0.81 
Waist circumference (cm) 104.08 (12.86) 101.90 (13.64) 104.27 (11.41) 101.01 (16.69) 0.79 
Resting metabolic rate (kcal/24 h) 1,564.29 (305.23) 1,521.42 (294.12) 1,547.67 (269.88) 1,522.53 (379.28) 0.67 
Respiratory quotient 0.84 (0.04) 0.84 (0.04) 0.85 (0.05) 0.83 (0.05) 0.34 
Physical activity score 1.59 (0.11) 1.57 (0.11) 1.57 (0.11) 1.54 (0.13) 0.23 
Body fat composition (%)      
 Whole-body total fat mass 37.04 (6.89) 37.30 (6.67) 36.69 (6.60) 40.26 (8.62) 0.49 
 Trunk fat 38.11 (6.04) 37.85 (5.57) 38.12 (5.93) 38.60 (11.56) 0.31 
Body fat distribution (kg)      
 DSAT 5.85 (1.63) 5.49 (1.74) 5.84 (1.81) 5.33 (1.65) 0.60 
 SAT mass 11.31 (2.66) 10.46 (2.26) 11.22 (2.84) 12.21 (6.05) 0.23 
 VAT mass 5.57 (2.54) 5.36 (2.65) 5.06 (2.17) 4.21 (2.02) 0.35 
 TAT mass 16.98 (3.99) 15.92 (4.01) 16.30 (3.84) 17.00 (8.54) 0.42 
Dietary intake/day      
 Energy (kcal) 1,949.40 (530.33) 1,994.09 (625.48) 1,973.77 (639.97) 1,983.88 (411.48) 0.34 
 Protein (%) 18.15 (3.35) 17.90 (3.19) 18.29 (3.79) 16.10 (2.78) 0.39 
 Fat (%) 36.93 (5.69) 36.87 (6.43) 36.81 (6.02) 37.97 (5.60) 0.94 
 Carbohydrate (%) 44.78 (7.62) 44.91 (7.60) 44.89 (7.18) 46.05 (7.84) 0.99 
OutcomesNot at all (n = 462)Slight (n = 236)Moderate (n = 95)Great (n = 17)P*
Age (years) 50.56 (9.03) 51.24 (9.34) 51.45 (9.80) 50.13 (8.83) 0.70 
Male 187 (40.48) 71 (30.08) 35 (36.84) 3 (17.65) 0.02 
High-fat diet 230 (49.78) 118 (50.00) 49 (51.58) 8 (47.06) 0.98 
BMI (kg/m232.74 (3.79) 32.57 (4.07) 32.97 (3.45) 31.94 (5.00) 0.82 
Body weight (kg) 93.43 (15.66) 91.67 (15.74) 93.91 (13.54) 89.98 (19.82) 0.81 
Waist circumference (cm) 104.08 (12.86) 101.90 (13.64) 104.27 (11.41) 101.01 (16.69) 0.79 
Resting metabolic rate (kcal/24 h) 1,564.29 (305.23) 1,521.42 (294.12) 1,547.67 (269.88) 1,522.53 (379.28) 0.67 
Respiratory quotient 0.84 (0.04) 0.84 (0.04) 0.85 (0.05) 0.83 (0.05) 0.34 
Physical activity score 1.59 (0.11) 1.57 (0.11) 1.57 (0.11) 1.54 (0.13) 0.23 
Body fat composition (%)      
 Whole-body total fat mass 37.04 (6.89) 37.30 (6.67) 36.69 (6.60) 40.26 (8.62) 0.49 
 Trunk fat 38.11 (6.04) 37.85 (5.57) 38.12 (5.93) 38.60 (11.56) 0.31 
Body fat distribution (kg)      
 DSAT 5.85 (1.63) 5.49 (1.74) 5.84 (1.81) 5.33 (1.65) 0.60 
 SAT mass 11.31 (2.66) 10.46 (2.26) 11.22 (2.84) 12.21 (6.05) 0.23 
 VAT mass 5.57 (2.54) 5.36 (2.65) 5.06 (2.17) 4.21 (2.02) 0.35 
 TAT mass 16.98 (3.99) 15.92 (4.01) 16.30 (3.84) 17.00 (8.54) 0.42 
Dietary intake/day      
 Energy (kcal) 1,949.40 (530.33) 1,994.09 (625.48) 1,973.77 (639.97) 1,983.88 (411.48) 0.34 
 Protein (%) 18.15 (3.35) 17.90 (3.19) 18.29 (3.79) 16.10 (2.78) 0.39 
 Fat (%) 36.93 (5.69) 36.87 (6.43) 36.81 (6.02) 37.97 (5.60) 0.94 
 Carbohydrate (%) 44.78 (7.62) 44.91 (7.60) 44.89 (7.18) 46.05 (7.84) 0.99 

Data are mean (SD) or n (%) unless otherwise indicated.

DSAT, deep subcutaneous adipose tissue; SAT, superficial adipose tissue; TAT, total adipose tissue by CT; VAT, visceral adipose tissue.

*

P value adjusted for age, sex, and ethnicity.

During the weight loss period, we found that higher levels of sleep disturbance from baseline to 6 months were significantly associated with less weight loss at 6 months after adjustment for covariates (Ptrend <0.001) (Table 2). A similar linear trend was observed for waist circumference. However, among successful weight losers who lost at least 5% of their initial weight at 6 months, no statistically significant association was detected between repeated measurements of sleep disturbance and body weight or waist circumference changes for 6 months during the weight regain period. For the entire 2-year period, repeated measures of sleep disturbance were significantly related with the overall rate of changes in body weight (Ptrend <0.001) and waist circumference (Ptrend ≤0.001) (weight change per 6 months; waist circumference change per 6 months). Participants suffering from higher levels of sleep disturbance lost significantly less weight and waist circumference over the 2-year trial. The trajectories of changes in body weight and waist circumference according to sleep disturbance among all participants over 2 years are shown in Fig. 1.

Figure 1

Trajectory of changes in body weight (kilograms) and waist circumference among all participants according to sleep disturbance over 2 years. Data were LS means, adjusted for age, sex, ethnicity, diet, BMI, physical activity score at baseline, and the respective variable (except for the outcome Δ weight) at the previous assessment.

Figure 1

Trajectory of changes in body weight (kilograms) and waist circumference among all participants according to sleep disturbance over 2 years. Data were LS means, adjusted for age, sex, ethnicity, diet, BMI, physical activity score at baseline, and the respective variable (except for the outcome Δ weight) at the previous assessment.

Close modal
Table 2

Changes in body weight and waist circumference for 6 months according to sleep disturbances

OutcomesNot at allSlightModerateGreatPtrend
0–6 months      
 Δ weight (kg)      
  Model 1* −6.06 (0.58) −4.81 (0.63) −4.74 (0.75) −2.41 (0.93) <0.001 
  Model 2 −6.14 (0.57) −4.83 (0.62) −4.79 (0.73) −2.15 (0.91) <0.001 
 Δ WC (cm)      
  Model 1* −6.17 (0.63) −5.66 (0.68) −5.39 (0.80) −3.42 (1.00) 0.005 
  Model 2 −6.26 (0.62) −5.69 (0.66) −5.45 (0.79) −3.15 (0.98) 0.002 
0–24 months      
 Δ weight (kg)      
  Model 3 −1.00 (0.23) −0.53 (0.24) −0.22 (0.30) 0.39 (0.33) <0.001 
  Model 4‖‖ −1.01 (0.24) −0.54 (0.25) −0.22 (0.31) 0.43 (0.37) <0.001 
 Δ WC (cm)      
  Model 3 −1.43 (0.26) −1.05 (0.26) −0.89 (0.32) −0.41 (0.38) 0.002 
  Model 4‖‖ −1.44 (0.27) −1.07 (0.27) −0.88 (0.32) −0.36 (0.38) 0.001 
6–24 months among those with successful weight loss (n = 421)      
 Δ weight (kg)      
  Model 3 0.82 (0.33) 0.79 (0.32) 1.40 (0.41) 1.10 (0.42) 0.14 
  Model 4‖‖ 0.88 (0.32) 0.86 (0.31) 1.43 (0.40) 1.07 (0.41) 0.20 
  Model 5 0.87 (0.32) 0.84 (0.31) 1.39 (0.41) 1.02 (0.42) 0.24 
 Δ WC (cm)      
  Model 3 0.11 (0.36) 0.38 (0.37) 0.93 (0.46) 0.38 (0.52) 0.06 
  Model 4‖‖ 0.16 (0.35) 0.45 (0.36) 0.95 (0.45) 0.33 (0.51) 0.08 
  Model 5 0.15 (0.35) 0.45 (0.36) 0.94 (0.45) 0.32 (0.51) 0.09 
OutcomesNot at allSlightModerateGreatPtrend
0–6 months      
 Δ weight (kg)      
  Model 1* −6.06 (0.58) −4.81 (0.63) −4.74 (0.75) −2.41 (0.93) <0.001 
  Model 2 −6.14 (0.57) −4.83 (0.62) −4.79 (0.73) −2.15 (0.91) <0.001 
 Δ WC (cm)      
  Model 1* −6.17 (0.63) −5.66 (0.68) −5.39 (0.80) −3.42 (1.00) 0.005 
  Model 2 −6.26 (0.62) −5.69 (0.66) −5.45 (0.79) −3.15 (0.98) 0.002 
0–24 months      
 Δ weight (kg)      
  Model 3 −1.00 (0.23) −0.53 (0.24) −0.22 (0.30) 0.39 (0.33) <0.001 
  Model 4‖‖ −1.01 (0.24) −0.54 (0.25) −0.22 (0.31) 0.43 (0.37) <0.001 
 Δ WC (cm)      
  Model 3 −1.43 (0.26) −1.05 (0.26) −0.89 (0.32) −0.41 (0.38) 0.002 
  Model 4‖‖ −1.44 (0.27) −1.07 (0.27) −0.88 (0.32) −0.36 (0.38) 0.001 
6–24 months among those with successful weight loss (n = 421)      
 Δ weight (kg)      
  Model 3 0.82 (0.33) 0.79 (0.32) 1.40 (0.41) 1.10 (0.42) 0.14 
  Model 4‖‖ 0.88 (0.32) 0.86 (0.31) 1.43 (0.40) 1.07 (0.41) 0.20 
  Model 5 0.87 (0.32) 0.84 (0.31) 1.39 (0.41) 1.02 (0.42) 0.24 
 Δ WC (cm)      
  Model 3 0.11 (0.36) 0.38 (0.37) 0.93 (0.46) 0.38 (0.52) 0.06 
  Model 4‖‖ 0.16 (0.35) 0.45 (0.36) 0.95 (0.45) 0.33 (0.51) 0.08 
  Model 5 0.15 (0.35) 0.45 (0.36) 0.94 (0.45) 0.32 (0.51) 0.09 

Data are LS means (SE). Δ weight and Δ WC were calculated as the changes for 6 months. Tests for linear trend across categories of sleep disturbance were performed by modeling an ordinal variable for each sleep category.

Δ WC, change in waist circumference.

*

Model 1: generalized linear model adjusted for age, sex, ethnicity, diet, BMI, and the respective variable (except for the outcome Δ weight) at the previous assessment.

Model 2: further adjusted for physical activity score at baseline.

Model 3: GEE assuming first-order autoregressive adjusted for age, sex, ethnicity, visit, diet, BMI, and the respective variable (except for the outcome Δ weight) at the previous assessment.

‖‖

Model 4: further adjusted for physical activity score at baseline.

Model 5: further adjusted for initial weight loss at 6 months.

We then investigated whether sleep disturbance from baseline to 6 months was significantly predictive of failure of weight loss at 6 months (Fig. 2). Among 810 participants, 48% (389 of 810) failed to lose at least 5% of their initial weight. Compared with individuals without sleep disturbance at all from baseline to 6 months, those with slight, moderate, or great sleep disturbance showed an elevated risk of failure to lose weight, with ORs of 1.24 (95% CI 0.87, 1.78), 1.27 (95% CI 0.75, 2.13), or 3.12 (95% CI 1.61, 6.03), respectively. We also conducted a sensitivity analysis for those who lost at least 10% of their initial weight in 6 months. In comparison with no sleep disturbance at all, the ORs of weight-loss failure at 6 months were 1.59 (95% CI 1.08, 2.32), 2.01(95% CI 1.11, 3.65), and 4.00 (95% CI 1.68, 9.48) for those with slight, moderate, or great sleep disturbance, respectively.

Figure 2

Probability of a failure of successful weight loss at 6 months according to sleep disturbance. ORs after adjustment for age, sex, ethnicity, baseline BMI, physical activity, and diet group. Successful weight loss is defined as weight loss >0%, ≥5%, and 10% of baseline body weight, respectively.

Figure 2

Probability of a failure of successful weight loss at 6 months according to sleep disturbance. ORs after adjustment for age, sex, ethnicity, baseline BMI, physical activity, and diet group. Successful weight loss is defined as weight loss >0%, ≥5%, and 10% of baseline body weight, respectively.

Close modal

In addition, greater sleep disturbance from baseline to 6 months was significantly associated with less decrease in total fat, total fat mass percentage, and trunk fat percentage, in the weight loss period (Ptrend = 0.02, 0.04, and 0.05, respectively). Significant associations were also observed in weight regain period between sleep disturbance recalled at 24 months and body composition (Ptrend = 0.02, <0.01, and <0.01, respectively) (Fig. 3 and Supplementary Table 2). The associations were more significant during the weight regain period. Interestingly, participants with moderate or great sleep disturbance showed an increased level of total fat mass percent and trunk fat percent, compared with baseline (the LS means of total fat mass percent change was 0.44 for moderate sleep disturbance and 0.65 for severe sleep disturbance; trunk fat percent change was 0.02 for moderate amount and 0.38 for severe sleep disturbance). No significant association was detected between sleep disturbance and less adiposity, possibly due to reduced statistical power (n = 107).

Figure 3

Trajectory of changes in total fat (grams), total fat mass (percentage), and trunk fat (percentage) among all participants according to sleep disturbance over 2 years. Data were LS means, adjusted for age, sex, ethnicity, diet, baseline physical activity, BMI, and the respective variable at previous visit.

Figure 3

Trajectory of changes in total fat (grams), total fat mass (percentage), and trunk fat (percentage) among all participants according to sleep disturbance over 2 years. Data were LS means, adjusted for age, sex, ethnicity, diet, baseline physical activity, BMI, and the respective variable at previous visit.

Close modal

We further investigated whether measures of appetite and food cravings at 6 months might mediate the relationship between sleep disturbance and weight loss from baseline to 6 months (Table 3). When food craving subscales from the FCI were further adjusted, the largest indirect effect was observed by craving for carbohydrates/starches, craving for fast-food fats, and craving for sweets (β = −0.09, −0.06, and −0.06, respectively). These medications are significant under the 95% confidence level. Additionally, appetite measurements using VAS ratings were also examined. Cravings, prospective consumption, and hunger scores showed significantly indirect effects and were associated with less weight changes in the weight-loss period (P < 0.05 for all). Similarly, inclusion of dietary restraint, disinhibition, and hunger in the model significantly reduced the strength of the relationship between sleep and weight loss by 16% ([−1.06 + 0.89]/−1.06), 29% ([−1.06 + 0.75]/−1.06), and 23% ([−1.06 + 0.82]/ −1.06), respectively (P < 0.05 for all). The combined psychologic and behavioral factors (total food craving index, appetite score, dietary restraint, disinhibition, and hunger) mediated up to 42% (−0.44/−1.06) of the total effect from sleep disturbance to weight loss. By combining the categories “slight” and “moderate” disturbance, the results were similarly significant in the main associations and mediation analyses.

Table 3

Weight loss outcomes after respectively accounting for each mediator from 0 to 6 months (n = 648)

Effectsβ (SE)* 
Total effect sleep disturbance → weight loss Through mediation variables (analyzed respectively)−1.06 (−1.51, −0.61)
Direct effect, β (SE)*
Indirect effect through mediators, β (SE)*
FCI   
 Craving carbohydrates/starches −0.98 (0.23) −0.09 (0.04) 
 Craving fast-food fats −1.00 (0.23) −0.06 (0.04) 
 Craving fruits and vegetables −1.03 (0.23) 0.03 (0.03) 
 Craving high-fat foods −1.05 (0.24) 0.02 (0.03) 
 Craving sweets −1.00 (0.23) −0.06 (−0.04) 
 FCI total score −0.97 (0.24) 0.09 (0.05) 
Appetite   
 Craving −0.98 (0.24) −0.09 (0.04) 
 Fullness −1.04 (0.23) 0.02 (0.02) 
 Prospective consumption −1.02 (0.23) −0.04 (0.03) 
 Hunger −0.97 (0.23) −0.09 (0.04) 
 Total appetite score −0.91 (0.23) −0.15 (0.06) 
TFEQ   
 Cognitive restraint of eating subscale −0.89 (0.22) −0.17 (0.08) 
 Disinhibition subscale −0.75 (0.23) −0.31 (0.09) 
 Hunger subscale −0.82 (0.23) −0.24 (0.07) 
FCI total score plus appetite score plus TFEQ −0.62 (0.22) −0.44 (0.12) 
Effectsβ (SE)* 
Total effect sleep disturbance → weight loss Through mediation variables (analyzed respectively)−1.06 (−1.51, −0.61)
Direct effect, β (SE)*
Indirect effect through mediators, β (SE)*
FCI   
 Craving carbohydrates/starches −0.98 (0.23) −0.09 (0.04) 
 Craving fast-food fats −1.00 (0.23) −0.06 (0.04) 
 Craving fruits and vegetables −1.03 (0.23) 0.03 (0.03) 
 Craving high-fat foods −1.05 (0.24) 0.02 (0.03) 
 Craving sweets −1.00 (0.23) −0.06 (−0.04) 
 FCI total score −0.97 (0.24) 0.09 (0.05) 
Appetite   
 Craving −0.98 (0.24) −0.09 (0.04) 
 Fullness −1.04 (0.23) 0.02 (0.02) 
 Prospective consumption −1.02 (0.23) −0.04 (0.03) 
 Hunger −0.97 (0.23) −0.09 (0.04) 
 Total appetite score −0.91 (0.23) −0.15 (0.06) 
TFEQ   
 Cognitive restraint of eating subscale −0.89 (0.22) −0.17 (0.08) 
 Disinhibition subscale −0.75 (0.23) −0.31 (0.09) 
 Hunger subscale −0.82 (0.23) −0.24 (0.07) 
FCI total score plus appetite score plus TFEQ −0.62 (0.22) −0.44 (0.12) 

Data in boldface are statistically significant mediation effects with 95% confidence.

*

Adjusted for age, sex, ethnicity, diet, physical activity score, and baseline BMI. Sleep disturbance is coded as an ordinal variable (0, 1, 2, or 3), indicating no, slight, moderate, and great sleep disturbance.

Indirect effect calculated through bootstrap. SEs are reported.

In this 2-year dietary intervention among participants who were overweight or obese, we found that higher levels of sleep disturbance were significantly associated with less weight loss both at 6 months and over 24 months and elevated risk of failure to lose >5% of initial weight at 6 months. Further, we found that sleep disturbance predicted less loss and larger regains in body fat composition and fat distribution. Our results also indicated that food cravings for carbohydrates/starches, fast-food fats, and sweets, respectively; cravings, prospective consumption, and hunger of appetite measurements; and dietary restraint, inhibition, and hunger subscale mediated the effects of sleep disturbance on weight loss.

In our analysis, levels of sleep disturbance from baseline to 6 months were significantly predictive of risk of failure to lose weight at 6 months. Consistent with our findings, randomized trials focusing on sleep restriction have reported that longer sleep duration favored success of a calorie-restricted weight-loss diet (16,36,37). In contrast to our findings, however, some studies have reported no association between weight loss and sleep restriction among participants during caloric restriction (12,13,18). In another weight-loss intervention trial among 245 women who were obese or overweight, subjective sleep quality and sleep duration, rather than sleep disturbance, predicted success of weight loss at 6 months. These discrepancies may be attributed to varying sample size and different characteristics of study participants, including age, sex, baseline BMI, the extent of sleep disturbance, and adherence to caloric restriction.

Few studies have explored the impact of sleep on body composition and adiposity. In a short, 4-week, randomized crossover study, 10 adults who were overweight spent two 14-day periods in the laboratory with scheduled time-in-bed of 8.5 or 5.5 h/night in random order. After the intervention, the 5.5-h time-in-bed condition resulted in less loss of body fat compared with the 8.5-h time-in-bed condition (P = 0.043) (12). In another 9-month longitudinal study providing a calorie-restricted Mediterranean diet, 224 Caucasian women sleeping 6–8 or >8 h/day had an increased probability of losing fat mass than women who reported sleeping <6 h/day (OR 4.47 [95% CI 1.42, 14.04], P = 0.010; and OR 5.10 [95% CI 1.15, 22.70], P = 0.032, respectively) (17). Similarly, Wang et al. (13) observed that among 41 individuals, after an 8-week intervention, the calorie-restriction group without sleep restriction lost a greater percentage of fat mass within the total mass lost than the calorie-restriction group with sleep restriction (P = 0.016). A recent study conducted among British, Danish, and Portuguese adults suggested that maintaining a consistent sleep onset is associated with improved weight-loss maintenance and fat percentage (38).

To our knowledge, the current investigation was among the largest and longest studies that have examined the role of sleep disturbance on changes in body composition and adiposity during weight loss and weight regain in a controlled clinical trial. Consistently, we found that greater levels of sleep disturbance were related with lower losses in fat mass and fat mass percent at 6 months. Three recent cross-sectional studies reported an inverse association between sleep problems and trunk fat measurements (3941). Our analysis extended those findings by showing similar patterns for trunk fat percent in a longitudinal weight loss intervention. Moreover, during the period of weight regain, participants with greater sleep disturbance tended to regain more fat mass, fat mass percentage, and trunk fat.

These findings were partly explained by changes of respiratory quotient toward less oxidation of fat among participants with greater levels of sleep disturbance, suggesting less utilization of fat (12,13). Consistent with past findings of sleep curtailment with elevated ghrelin (42,43), a 24-h experimental study among healthy young men indicated that sleep inhibited the acylation of ghrelin (44). Acylated ghrelin was considered as the only bioactive form of ghrelin (45). Compelling evidence from both animal and human studies has demonstrated its effects to stimulate appetite, promote accumulation of fat, and increase glucose release by hepatocytes to support the availability of fuel to glucose-dependent tissues (4650). Taken together, we speculate that sleep may interfere with fat metabolism, regardless of baseline weight. Further studies are warranted to investigate the mechanisms underlying our findings.

Mediation analysis suggests that the effects of sleep disturbance may be mediated by change in food cravings, hunger, and appetite (5154). Our results about food cravings measurements are in concordance with research stating that sleep was inversely associated with cravings for sweets, carbohydrates/starches, and fat (20,51,55). The mediation effect of cravings for carbohydrates/starches is the strongest among the FCI, suggesting that interventions targeting low carbohydrate/starches intake, such as reducing the availability and variety of carbohydrates, may benefit weight loss among people with sleep disturbance (56). Few studies have examined dietary restraint, disinhibition, and their mechanisms relating to sleep disturbance to increased BMI. Dietary restraint and disinhibition are significant predictors of successful weight loss and weight regain after weight-loss regimes (5759). Aligning with our results, researchers have suggested a significant indirect relationship between sleep quality and BMI via disinhibition in a cross-sectional study (60). Our study further showed the consistency in a longitudinal intervention. Disinhibition refers to the tendency to overeat under circumstances such as being presented with an array of palatable foods or under emotional distress. It has been consistently associated with weight change and showed stronger mediations in contrast to other factors (61). Our findings suggested that to improve disinhibited eating is particularly important for weight-loss interventions among the obese or overweight population with sleep disturbance, like cognitive therapy (62) or use of sibutramine (63). When controlling for all factors noted earlier, the overall mediation effect accounted for 44% of the total effect. However, the direct association between sleep disturbance and weight loss still remained significant, suggesting that partial mediation was present, and further researches about other underlying mechanism are clearly warranted.

Our study has several strengths. We conducted our analysis in thus far the largest and longest weight-loss dietary intervention trial, which could alleviate the potential influences by unknown confounders. Moreover, repeated measures of sleep disturbance improved the validity of our analysis. Sleep disturbance may be improved after the initiation of a calorie-restricted diet (64,65). Misclassification may be a threat to study validity, if only a baseline assessment is performed. Repeated measurements of sleep disturbance, body weight, body composition, adiposity, and potential mediators, as done in this study, could increase our statistical power and help capture the differences during weight loss and weight regain. Furthermore, a bidirectional relationship may exist between successful weight loss and sleep traits (66). The interpretation of our findings was facilitated by the longitudinal setting. Lastly, the randomized controlled design and validated measurement tools (15,29) would add robustness to our mediation analysis.

However, the results of this study must be interpreted in light of several limitations. First, sleep disturbance was self-reported and retrospectively collected during the diet intervention trial from 2003 to 2007, when objectively measured sleep traits like use of a tracking sensor were unavailable. In addition, secondary data do not allow us to explore different domains of sleep patterns separately (67).

Furthermore, compared with characteristics of a general population of the U.S. in the National Health and Nutrition Examination Survey, the homogeneity among our participants (White, well-educated, nonsmoker, etc.) might undermine the generalizability of our findings.

In conclusion, in this long-term calorie-restricted dietary intervention trial, higher levels of sleep disturbance were significantly associated with less weight loss at 6 months and over the entire 2 years. Changes in body composition and adiposity during weight loss and weight regain were predicted by sleep disturbance. In addition, changes in appetite and food cravings partly mediated the effects of sleep disturbance on weight loss.

Clinical trial reg. no. NCT00072995, clinicaltrials.gov

This article contains supplementary material online at https://doi.org/10.2337/figshare.19178375.

Acknowledgments. The authors thank all of the participants in the study for the dedication and contribution to the research. The authors also thank the Preventive Research Laboratory and Laboratory Diagnostic Core, Cleveland Clinic, for the measurements.

Funding. The study is supported by National Institutes of Health grants from the National Heart, Lung, and Blood Institute (HL071981, HL034594, and HL126024), the National Institute of Diabetes and Digestive and Kidney Diseases (DK115679, DK091718, DK100383, and DK078616), the Boston Obesity Nutrition Research Center (DK46200), and by U.S.–Israel Binational Science Foundation grant 2011036. L.Q. is a recipient of the American Heart Association Scientist Development award (0730094N). T.Z. is a recipient of a scholarship under the China Scholarship Council to pursue studies in the U.S. (201606240145).

The sponsors had no role in the design or conduct of the study.

Duality of Interest. No potential conflicts of interest relevant to this article were reported.

Author Contributions. A.L. contributed to the study concept and design, analysis and interpretation of data, drafting and revision of the manuscript, statistical analysis, and study supervision. X.L., T.Z., H.M., and Y.H. contributed to analysis and interpretation of data and drafting and revision of the manuscript. G.A.B., D.A.W., S.R.S., and F.M.S. contributed to acquisition of data, interpretation of data, and drafting and revision of the manuscript. L.Q. contributed to the study concept and design, acquisition of data, analysis, and interpretation of data, drafting and revision of the manuscript, statistical analysis, obtainment of funding, and study supervision. L.Q. is the guarantor of this work and, as such, had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

1.
Singh
GM
,
Danaei
G
,
Farzadfar
F
, et al.;
Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group; Asia-Pacific Cohort Studies Collaboration (APCSC)
;
Diabetes Epidemiology: Collaborative analysis of Diagnostic criteria in Europe (DECODE)
;
Emerging Risk Factor Collaboration (ERFC)
;
Prospective Studies Collaboration (PSC)
.
The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: a pooled analysis
.
PLoS One
2013
;
8
:
e65174
2.
Barte
JC
,
ter Bogt
NC
,
Bogers
RP
, et al
.
Maintenance of weight loss after lifestyle interventions for overweight and obesity, a systematic review
.
Obes Rev
2010
;
11
:
899
906
3.
Heianza
Y
,
Qi
L
.
Gene-diet interaction and precision nutrition in obesity
.
Int J Mol Sci
2017
;
18
:
787
4.
Li
X
,
Qi
L
.
Gene-environment interactions on body fat distribution
.
Int J Mol Sci
2019
;
20
:
3690
5.
Wang
T
,
Heianza
Y
,
Sun
D
, et al
.
Improving adherence to healthy dietary patterns, genetic risk, and long term weight gain: gene-diet interaction analysis in two prospective cohort studies
.
BMJ
2018
;
360
:
j5644
6.
Bray
GA
,
Ryan
DH
,
Johnson
W
, et al
.
Markers of dietary protein intake are associated with successful weight loss in the POUNDS Lost trial
.
Clin Obes
2017
;
7
:
166
175
7.
Cappuccio
FP
,
Taggart
FM
,
Kandala
NB
, et al
.
Meta-analysis of short sleep duration and obesity in children and adults
.
Sleep
2008
;
31
:
619
626
8.
Wu
Y
,
Zhai
L
,
Zhang
D
.
Sleep duration and obesity among adults: a meta-analysis of prospective studies
.
Sleep Med
2014
;
15
:
1456
1462
9.
Fatima
Y
,
Doi
SA
,
Mamun
AA
.
Sleep quality and obesity in young subjects: a meta-analysis
.
Obes Rev
2016
;
17
:
1154
1166
10.
Capers
PL
,
Fobian
AD
,
Kaiser
KA
,
Borah
R
,
Allison
DB
.
A systematic review and meta-analysis of randomized controlled trials of the impact of sleep duration on adiposity and components of energy balance
.
Obes Rev
2015
;
16
:
771
782
11.
Patel
SR
,
Hu
FB
.
Short sleep duration and weight gain: a systematic review
.
Obesity (Silver Spring)
2008
;
16
:
643
653
12.
Nedeltcheva
AV
,
Kilkus
JM
,
Imperial
J
,
Schoeller
DA
,
Penev
PD
.
Insufficient sleep undermines dietary efforts to reduce adiposity
.
Ann Intern Med
2010
;
153
:
435
441
13.
Wang
X
,
Sparks
JR
,
Bowyer
KP
,
Youngstedt
SD
.
Influence of sleep restriction on weight loss outcomes associated with caloric restriction
.
Sleep (Basel)
2018
;
41
:
zsy027
14.
Chaput
JP
,
Tremblay
A
.
Sleeping habits predict the magnitude of fat loss in adults exposed to moderate caloric restriction
.
Obes Facts
2012
;
5
:
561
566
15.
Moreno
S
,
Rodríguez
S
,
Fernandez
MC
,
Tamez
J
,
Cepeda-Benito
A
.
Clinical validation of the trait and state versions of the Food Craving Questionnaire
.
Assessment
2008
;
15
:
375
387
16.
Elder
CR
,
Gullion
CM
,
Funk
KL
,
Debar
LL
,
Lindberg
NM
,
Stevens
VJ
.
Impact of sleep, screen time, depression and stress on weight change in the intensive weight loss phase of the LIFE study
.
Int J Obes
2012
;
36
:
86
92
17.
Pagliai
G
,
Dinu
M
,
Casini
A
,
Sofi
F
.
Relationship between sleep pattern and efficacy of calorie-restricted Mediterranean diet in overweight/obese subjects
.
Int J Food Sci Nutr
2018
;
69
:
93
99
18.
Thomson
CA
,
Morrow
KL
,
Flatt
SW
, et al
.
Relationship between sleep quality and quantity and weight loss in women participating in a weight-loss intervention trial
.
Obesity (Silver Spring)
2012
;
20
:
1419
1425
19.
Sallinen
BJ
,
Hassan
F
,
Olszewski
A
, et al
.
Longer weekly sleep duration predicts greater 3-month BMI reduction among obese adolescents attending a clinical multidisciplinary weight management program
.
Obes Facts
2013
;
6
:
239
246
20.
Lv
W
,
Finlayson
G
,
Dando
R
.
Sleep, food cravings and taste
.
Appetite
2018
;
125
:
210
216
21.
Lin
J
,
Jiang
Y
,
Wang
G
, et al
.
Associations of short sleep duration with appetite-regulating hormones and adipokines: a systematic review and meta-analysis
.
Obes Rev
2020
;
21
:
e13051
22.
Li
D
,
Liu
D
,
Wang
X
,
He
D
.
Self-reported habitual snoring and risk of cardiovascular disease and all-cause mortality
.
Atherosclerosis
2014
;
235
:
189
195
23.
Sacks
FM
,
Bray
GA
,
Carey
VJ
, et al
.
Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates
.
N Engl J Med
2009
;
360
:
859
873
24.
de Souza
RJ
,
Bray
GA
,
Carey
VJ
, et al
.
Effects of 4 weight-loss diets differing in fat, protein, and carbohydrate on fat mass, lean mass, visceral adipose tissue, and hepatic fat: results from the POUNDS LOST trial
.
Am J Clin Nutr
2012
;
95
:
614
625
25.
Heianza
Y
,
Sun
D
,
Smith
SR
,
Bray
GA
,
Sacks
FM
,
Qi
L
.
Changes in gut microbiota-related metabolites and long-term successful weight loss in response to weight-loss diets: the POUNDS Lost trial
.
Diabetes Care
2018
;
41
:
413
419
26.
Thomas
DM
,
Ivanescu
AE
,
Martin
CK
, et al
.
Predicting successful long-term weight loss from short-term weight-loss outcomes: new insights from a dynamic energy balance model (the POUNDS Lost study)
.
Am J Clin Nutr
2015
;
101
:
449
454
27.
Patel
S
,
Lochhead
PA
,
Rena
G
,
Sutherland
C
.
Antagonistic effects of phorbol esters on insulin regulation of insulin-like growth factor-binding protein-1 (IGFBP-1) but not glucose-6-phosphatase gene expression
.
Biochem J
2001
;
359
:
611
619
28.
de Jonge
L
,
Bray
GA
,
Smith
SR
, et al
.
Effect of diet composition and weight loss on resting energy expenditure in the POUNDS LOST study
.
Obesity (Silver Spring)
2012
;
20
:
2384
2389
29.
White
MA
,
Whisenhunt
BL
,
Williamson
DA
,
Greenway
FL
,
Netemeyer
RG
.
Development and validation of the food-craving inventory
.
Obes Res
2002
;
10
:
107
114
30.
Anderson
GH
,
Catherine
NL
,
Woodend
DM
,
Wolever
TM
.
Inverse association between the effect of carbohydrates on blood glucose and subsequent short-term food intake in young men
.
Am J Clin Nutr
2002
;
76
:
1023
1030
31.
Samra
RA
,
Anderson
GH
.
Insoluble cereal fiber reduces appetite and short-term food intake and glycemic response to food consumed 75 min later by healthy men
.
Am J Clin Nutr
2007
;
86
:
972
979
32.
Huang
T
,
Qi
Q
,
Li
Y
, et al
.
FTO genotype, dietary protein, and change in appetite: the Preventing Overweight Using Novel Dietary Strategies trial
.
Am J Clin Nutr
2014
;
99
:
1126
1130
33.
Stubbs
RJ
,
Hughes
DA
,
Johnstone
AM
, et al
.
The use of visual analogue scales to assess motivation to eat in human subjects: a review of their reliability and validity with an evaluation of new hand-held computerized systems for temporal tracking of appetite ratings
.
Br J Nutr
2000
;
84
:
405
415
34.
Stunkard
AJ
,
Messick
S
.
The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger
.
J Psychosom Res
1985
;
29
:
71
83
35.
Baecke
JA
,
Burema
J
,
Frijters
JE
.
A short questionnaire for the measurement of habitual physical activity in epidemiological studies
.
Am J Clin Nutr
1982
;
36
:
936
942
36.
St-Onge
MP
,
O’Keeffe
M
,
Roberts
AL
,
RoyChoudhury
A
,
Laferrère
B
.
Short sleep duration, glucose dysregulation and hormonal regulation of appetite in men and women
.
Sleep (Basel)
2012
;
35
:
1503
1510
37.
Moreno-Frías
C
,
Figueroa-Vega
N
,
Malacara
JM
.
Sleep extension increases the effect of caloric restriction over body weight and improves the chronic low-grade inflammation in adolescents with obesity
.
J Adolesc Health
2020
;
66
:
575
581
38.
Larsen
SC
,
Horgan
G
,
Mikkelsen
MK
, et al
.
Consistent sleep onset and maintenance of body weight after weight loss: an analysis of data from the NoHoW trial
.
PLoS Med
2020
;
17
:
e1003168
39.
Rosique-Esteban
N
,
Papandreou
C
,
Romaguera
D
, et al
.
Cross-sectional associations of objectively-measured sleep characteristics with obesity and type 2 diabetes in the PREDIMED-Plus trial
.
Sleep (Basel)
2018
;
41
:
zsy190
40.
Tan
X
,
Alén
M
,
Cheng
SM
, et al
.
Associations of disordered sleep with body fat distribution, physical activity and diet among overweight middle-aged men
.
J Sleep Res
2015
;
24
:
414
424
41.
Liu
R
,
Liu
X
,
Arguelles
LM
, et al
.
A population-based twin study on sleep duration and body composition
.
Obesity (Silver Spring)
2012
;
20
:
192
199
42.
Spiegel
K
,
Tasali
E
,
Penev
P
,
Van Cauter
E
.
Brief communication: sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite
.
Ann Intern Med
2004
;
141
:
846
850
43.
Taheri
S
,
Lin
L
,
Austin
D
,
Young
T
,
Mignot
E
.
Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index
.
PLoS Med
2004
;
1
:
e62
44.
Spiegel
K
,
Tasali
E
,
Leproult
R
,
Scherberg
N
,
Van Cauter
E
.
Twenty-four-hour profiles of acylated and total ghrelin: relationship with glucose levels and impact of time of day and sleep
.
J Clin Endocrinol Metab
2011
;
96
:
486
493
45.
Chabot
F
,
Caron
A
,
Laplante
M
,
St-Pierre
DH
.
Interrelationships between ghrelin, insulin and glucose homeostasis: physiological relevance
.
World J Diabetes
2014
;
5
:
328
341
46.
Rodríguez
A
,
Gómez-Ambrosi
J
,
Catalán
V
, et al
.
Acylated and desacyl ghrelin stimulate lipid accumulation in human visceral adipocytes
.
Int J Obes
2009
;
33
:
541
552
47.
Tschöp
M
,
Smiley
DL
,
Heiman
ML
.
Ghrelin induces adiposity in rodents
.
Nature
2000
;
407
:
908
913
48.
Lv
Y
,
Liang
T
,
Wang
G
,
Li
Z
.
Ghrelin, a gastrointestinal hormone, regulates energy balance and lipid metabolism
.
Biosci Rep
2018
;
38
:
BSR20181061
49.
Dezaki
K
,
Sone
H
,
Yada
T
.
Ghrelin is a physiological regulator of insulin release in pancreatic islets and glucose homeostasis
.
Pharmacol Ther
2008
;
118
:
239
249
50.
Gauna
C
,
Delhanty
PJ
,
Hofland
LJ
, et al
.
Ghrelin stimulates, whereas des-octanoyl ghrelin inhibits, glucose output by primary hepatocytes
.
J Clin Endocrinol Metab
2005
;
90
:
1055
1060
51.
Yang
CL
,
Schnepp
J
,
Tucker
RM
.
Increased hunger, food cravings, food reward, and portion size selection after sleep curtailment in women without obesity
.
Nutrients
2019
;
11
:
E663
52.
Kracht
CL
,
Chaput
JP
,
Martin
CK
,
Champagne
CM
,
Katzmarzyk
PT
,
Staiano
AE
.
Associations of sleep with food cravings, diet, and obesity in adolescence
.
Nutrients
2019
;
11
:
E2899
53.
Zhu
B
,
Shi
C
,
Park
CG
,
Zhao
X
,
Reutrakul
S
.
Effects of sleep restriction on metabolism-related parameters in healthy adults: a comprehensive review and meta-analysis of randomized controlled trials
.
Sleep Med Rev
2019
;
45
:
18
30
54.
St-Onge
MP
.
Sleep-obesity relation: underlying mechanisms and consequences for treatment
.
Obes Rev
2017
;
18
(
Suppl. 1
):
34
39
55.
Martinez
SM
,
Tschann
JM
,
Butte
NF
, et al
.
Short sleep duration is associated with eating more carbohydrates and less dietary fat in Mexican American children
.
Sleep (Basel)
2017
;
40
:
zsw057
56.
McCrory
MA
,
Fuss
PJ
,
McCallum
JE
, et al
.
Dietary variety within food groups: association with energy intake and body fatness in men and women
.
Am J Clin Nutr
1999
;
69
:
440
447
57.
Bryant
EJ
,
King
NA
,
Blundell
JE
.
Disinhibition: its effects on appetite and weight regulation
.
Obes Rev
2008
;
9
:
409
419
58.
Teixeira
PJ
,
Going
SB
,
Houtkooper
LB
, et al
.
Exercise motivation, eating, and body image variables as predictors of weight control
.
Med Sci Sports Exerc
2006
;
38
:
179
188
59.
Hege
MA
,
Stingl
KT
,
Veit
R
,
Preissl
H
.
Modulation of attentional networks by food-related disinhibition
.
Physiol Behav
2017
;
176
:
84
92
60.
Blumfield
ML
,
Bei
B
,
Zimberg
IZ
,
Cain
SW
.
Dietary disinhibition mediates the relationship between poor sleep quality and body weight
.
Appetite
2018
;
120
:
602
608
61.
Hays
NP
,
Roberts
SB
.
Aspects of eating behaviors “disinhibition” and “restraint” are related to weight gain and BMI in women
.
Obesity (Silver Spring)
2008
;
16
:
52
58
62.
Pacanowski
CR
,
Mason
TB
,
Crosby
RD
, et al
.
Weight change over the course of binge eating disorder treatment: relationship to binge episodes and psychological factors
.
Obesity (Silver Spring)
2018
;
26
:
838
844
63.
Wilfley
DE
,
Crow
SJ
,
Hudson
JI
, et al.;
Sibutramine Binge Eating Disorder Research Group
.
Efficacy of sibutramine for the treatment of binge eating disorder: a randomized multicenter placebo-controlled double-blind study
.
Am J Psychiatry
2008
;
165
:
51
58
64.
Martin
CK
,
Bhapkar
M
,
Pittas
AG
, et al.;
Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy (CALERIE) Phase 2 Study Group
.
Effect of calorie restriction on mood, quality of life, sleep, and sexual function in healthy nonobese adults: the CALERIE 2 randomized clinical trial
.
JAMA Intern Med
2016
;
176
:
743
752
65.
Castro
AI
,
Gomez-Arbelaez
D
,
Crujeiras
AB
, et al
.
Effect of a very low-calorie ketogenic diet on food and alcohol cravings, physical and sexual activity, sleep disturbances, and quality of life in obese patients
.
Nutrients
2018
;
10
:
E1348
66.
Alfaris
N
,
Wadden
TA
,
Sarwer
DB
, et al
.
Effects of a 2-year behavioral weight loss intervention on sleep and mood in obese individuals treated in primary care practice
.
Obesity (Silver Spring)
2015
;
23
:
558
564
67.
Fan
M
,
Sun
D
,
Zhou
T
, et al
.
Sleep patterns, genetic susceptibility, and incident cardiovascular disease: a prospective study of 385 292 UK Biobank participants
.
Eur Heart J
2020
;
41
:
1182
1189
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://diabetesjournals.org/journals/pages/license.